{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:29:31Z","timestamp":1793489371003,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179422","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:56:33Z","timestamp":1792248993000},"page":"179422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Amifostine attenuates pressure overload\u2013induced cardiac hypertrophy and metabolic remodeling via the SIRT1\/PPAR-\u03b1 axis in rats"],"prefix":"10.1016","volume":"1038","author":[{"given":"Mohammad","family":"Shahbazian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Imani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi Sadat","family":"Seyyedebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Rakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179422_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/15376516.2023.2238069","article-title":"Modulatory effect of amifostine (WR-1065) against genotoxicity and oxidative stress induced by methotrexate in human umbilical vein endothelial cells (HUVECs)","volume":"33","author":"Aghajanshakeri","year":"2023","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ejphar.2026.179422_bib2","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1002\/jcb.27985","article-title":"Improved angiogenic activity of endothelial progenitor cell in diabetic patients treated with insulin plus metformin","volume":"120","author":"Asadian","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.179422_bib3","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1002\/jcb.26777","article-title":"Increased circulation mobilization of endothelial progenitor cells in preterm infants with retinopathy of prematurity","volume":"119","author":"Babaei","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.179422_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116962","article-title":"'Fatty acid synthase inhibition offers protection against pressure-induced cardiac hypertrophy'","volume":"238","author":"Bharati","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019194","article-title":"Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats","volume":"6","author":"Braidy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179422_bib6","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvy131","article-title":"'Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2\/3 transactivation'","volume":"114","author":"Bugyei-Twum","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvy131","article-title":"Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2\/3 transactivation","volume":"114","author":"Bugyei-Twum","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193553","article-title":"'Pathological hypertrophy and cardiac dysfunction are linked to aberrant endogenous unsaturated fatty acid metabolism'","volume":"13","author":"Casquel De Tomasi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179422_bib9","volume":"vol. 23","author":"Caturano","year":"2022"},{"key":"10.1016\/j.ejphar.2026.179422_bib10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/db24-0240","article-title":"PAK3 exacerbates cardiac lipotoxicity via SREBP1c in obesity cardiomyopathy","volume":"73","author":"Chen","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2026.179422_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5114\/fn.2020.102436","article-title":"Amifostine ameliorates cerebral ischaemia-reperfusion injury via p38-mediated oxidative stress and mitochondrial dysfunction","volume":"58","author":"Cheng","year":"2020","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.ejphar.2026.179422_bib12","article-title":"Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II","volume":"16","author":"Cui","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174858","article-title":"Acacetin ameliorates cardiac hypertrophy by activating Sirt1\/AMPK\/PGC-1\u03b1 pathway","volume":"920","author":"Cui","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ejphar.2026.179422_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1491582","article-title":"'Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids'","volume":"16","author":"Fan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.7150\/ijms.107224","article-title":"CD36 knockdown attenuates pressure overload-induced cardiac injury by preventing lipotoxicity and improving myocardial energy metabolism","volume":"22","author":"Geng","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2026.179422_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.12997\/jla.2020.9.1.66","article-title":"'CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction'","volume":"9","author":"Glatz","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.ejphar.2026.179422_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1603316","article-title":"'Qingda granule prevents Ang II-induced cardiac hypertrophy via inhibiting NF-\u03baB signaling pathway'","volume":"16","author":"Gong","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40001-023-01623-4","article-title":"Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+\/SIRT1\/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism","volume":"29","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.821317","article-title":"NEU1 regulates mitochondrial energy metabolism and oxidative stress post-myocardial infarction in mice via the SIRT1\/PGC-1 alpha axis","volume":"9","author":"Guo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179422_bib21","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41598-023-27611-6","article-title":"Caloric restriction increases the resistance of aged heart to myocardial ischemia\/reperfusion injury via modulating AMPK\u2013SIRT1\u2013PGC1a energy metabolism pathway","volume":"13","author":"Guo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179422_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41401-020-0401-y","article-title":"Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPAR\u03b1\/PGC-1 pathway","volume":"42","author":"Hou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.179422_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2013.03.015","article-title":"'Redox regulation of SIRT1 in inflammation and cellular senescence'","volume":"61","author":"Hwang","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179422_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mvr.2018.02.005","article-title":"Hyperbilirubinemia-induced pro-angiogenic activity of infantile endothelial progenitor cells","volume":"118","author":"Jabarpour","year":"2018","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib25","first-page":"568","article-title":"Pressure overload-induced cardiac hypertrophy varies according to different ligation needle sizes and body weights in mice","volume":"110","author":"Jia","year":"2018","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000502979","article-title":"Use of amifostine for cytoprotection during radiation therapy: a review","volume":"98","author":"King","year":"2020","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2026.179422_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/0891060310002168","article-title":"Effects of amifostine on radiation-induced cardiac damage","volume":"42","author":"Kruse","year":"2003","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ejphar.2026.179422_bib28","doi-asserted-by":"crossref","first-page":"9958","DOI":"10.1038\/s41598-017-10523-7","article-title":"PPAR\u03b1-dependent Insig2a overexpression inhibits SREBP-1c processing during fasting","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179422_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70274","article-title":"Kallistatin improves lipid metabolism and alleviates cardiac hypertrophy via the SIRT1\/PPAR pathway: an experimental study","volume":"39","author":"Li","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179422_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/EC9.0000000000000024","article-title":"The role of lipotoxicity in cardiovascular disease","volume":"2","author":"Li","year":"2022","journal-title":"Emerg. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2026.179422_bib31","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fendo.2022.1074911","article-title":"PPAR\u03b1: an emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179422_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175155","article-title":"SUMOylation of SIRT1 activating PGC-1\u03b1\/PPAR\u03b1 pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy","volume":"930","author":"Liu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jare.2024.02.008","article-title":"Valerenic acid attenuates pathological myocardial hypertrophy by promoting the utilization of multiple substrates in the mitochondrial energy metabolism","volume":"68","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.06.008","article-title":"Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart","volume":"146","author":"Liu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib35","article-title":"'Early treatment with nootkatone prevents pressure overload-induced ventricular remodeling and heart failure'","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1423-0127-21-57","article-title":"Downregulation of Sirt1 as aging change in advanced heart failure","volume":"21","author":"Lu","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2026.179422_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl3549","article-title":"Proline metabolic reprogramming modulates cardiac remodeling induced by pressure overload in the heart","volume":"10","author":"Lv","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2026.179422_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.016489","article-title":"Differentiating left ventricular remodeling in aortic stenosis from systemic hypertension","volume":"17","author":"Mahmod","year":"2024","journal-title":"Circ., Cardiovasc. Imaging"},{"key":"10.1016\/j.ejphar.2026.179422_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40292-022-00520-x","article-title":"New evidence about aortic valve stenosis and cardiovascular hemodynamics","volume":"29","author":"Mancusi","year":"2022","journal-title":"High Blood Pres. Cardiovasc. Prev."},{"key":"10.1016\/j.ejphar.2026.179422_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"'Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential'","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib41","doi-asserted-by":"crossref","first-page":"H1375","DOI":"10.1152\/ajpheart.00053.2015","article-title":"The role of sirtuins in cardiac disease","volume":"309","author":"Matsushima","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cmet.2011.10.001","article-title":"PPAR\u03b1-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway","volume":"14","author":"Oka","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2026.179422_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179422_bib44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPAR\u03b1 to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib45","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1113\/JP284566","article-title":"Regulation of cardiomyocyte t-tubule structure by preload and afterload: roles in cardiac compensation and decompensation","volume":"602","author":"Ruud","year":"2024","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12272-023-01441-6","article-title":"Regulation of NOX\/p38 MAPK\/PPAR\u03b1 pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight","volume":"46","author":"Salama","year":"2023","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2026.179422_bib47","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid use and misuse by the heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib48","article-title":"Lipoprotein lipase as a target for obesity\/diabetes related cardiovascular disease","volume":"27","author":"Shang","year":"2024","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.179422_bib49","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","article-title":"Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179422_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111956","article-title":"Echinacoside ameliorates alcohol-induced oxidative stress and hepatic steatosis by affecting SREBP1c\/FASN pathway via PPAR\u03b1","volume":"148","author":"Tao","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179422_bib51","first-page":"355","article-title":"'Protective Effect of Amifostine on Radiotherapy-Applied Cardiovascular Tissue'","volume":"29","author":"Taylan","year":"2025","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib52","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/biology11050792","article-title":"PPAR alpha as a metabolic modulator of the liver: role in the pathogenesis of nonalcoholic steatohepatitis (NASH)","volume":"11","author":"Todisco","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2026.179422_bib53","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2003.09.071","article-title":"The potential cardioprotective effects of amifostine in irradiated rats","volume":"58","author":"Tokatli","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejphar.2026.179422_bib54","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.2147\/DDDT.S421894","article-title":"The anti-inflammatory mediator 17(R)-Resolvin D1 attenuates pressure overload-induced cardiac hypertrophy and fibrosis","volume":"17","author":"Wang","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.179422_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110920","article-title":"SIRT6 activates PPAR\u03b1 to improve doxorubicin-induced myocardial cell aging and damage","volume":"392","author":"Wang","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.179422_bib56","article-title":"Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebiom.2018.08.022","article-title":"TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice","volume":"36","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2026.179422_bib58","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1007\/s12035-017-0646-8","article-title":"Inhibition of Poly(ADP-ribose) Polymerase-1 enhances gene expression of selected sirtuins and APP cleaving enzymes in amyloid beta cytotoxicity","volume":"55","author":"Wencel","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179422_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12763","article-title":"Glucagon\u2010like peptide\u20101 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPAR \u03b1 pathway","volume":"17","author":"Wu","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2026.179422_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4130824","article-title":"Amifostine pretreatment attenuates myocardial ischemia\/reperfusion injury by inhibiting apoptosis and oxidative stress","volume":"2017","author":"Wu","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.179422_bib61","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3389\/fphar.2020.01133","article-title":"Energy metabolism in exercise-induced physiologic cardiac hypertrophy","volume":"11","author":"Xiang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib62","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/ijms23020996","article-title":"Deranged myocardial fatty acid metabolism in heart failure","volume":"23","author":"Yamamoto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179422_bib63","first-page":"2022","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179422_bib64","article-title":"Inhibition of TLR4\/MAPKs pathway contributes to the protection of salvianolic acid a against lipotoxicity-induced myocardial damage in cardiomyocytes and obese mice","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179422_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112029","article-title":"Effects of dibutyl phthalate on lipid metabolism in liver and hepatocytes based on PPAR\u03b1\/SREBP-1c\/FAS\/GPAT\/AMPK signal pathway","volume":"149","author":"Zhang","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179422_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.722908","article-title":"FABP3 deficiency exacerbates metabolic derangement in cardiac hypertrophy and heart failure via PPAR\u03b1 pathway","volume":"8","author":"Zhuang","year":"2021","journal-title":"Front. Cardiovasc. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:16:16Z","timestamp":1793488576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926009040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":66,"alternative-id":["S0014299926009040"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179422","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amifostine attenuates pressure overload\u2013induced cardiac hypertrophy and metabolic remodeling via the SIRT1\/PPAR-\u03b1 axis in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179422"}}